1. Introduction
===============

Octocorals, particularly, soft corals belonging to the genus *Sinularia*, have been demonstrated to be rich sources of bioactive natural products \[[@B1-marinedrugs-11-01999],[@B2-marinedrugs-11-01999]\]. Previous chemical investigations on *Sinularia flexibilis*, an octocoral distributed widely in the tropical and subtropical waters of the Indo-Pacific Ocean, have yielded a series of interesting cembrane-type diterpenoids \[[@B3-marinedrugs-11-01999],[@B4-marinedrugs-11-01999],[@B5-marinedrugs-11-01999],[@B6-marinedrugs-11-01999],[@B7-marinedrugs-11-01999],[@B8-marinedrugs-11-01999],[@B9-marinedrugs-11-01999],[@B10-marinedrugs-11-01999],[@B11-marinedrugs-11-01999],[@B12-marinedrugs-11-01999],[@B13-marinedrugs-11-01999],[@B14-marinedrugs-11-01999],[@B15-marinedrugs-11-01999],[@B16-marinedrugs-11-01999],[@B17-marinedrugs-11-01999],[@B18-marinedrugs-11-01999],[@B19-marinedrugs-11-01999],[@B20-marinedrugs-11-01999]\], and most of these compounds have been shown to possess various bioactivities, such as cytotoxic \[[@B4-marinedrugs-11-01999],[@B6-marinedrugs-11-01999],[@B11-marinedrugs-11-01999],[@B12-marinedrugs-11-01999],[@B13-marinedrugs-11-01999],[@B14-marinedrugs-11-01999],[@B15-marinedrugs-11-01999],[@B16-marinedrugs-11-01999],[@B17-marinedrugs-11-01999],[@B20-marinedrugs-11-01999],[@B21-marinedrugs-11-01999]\], anti-inflammatory \[[@B19-marinedrugs-11-01999],[@B20-marinedrugs-11-01999]\], neuroprotective \[[@B19-marinedrugs-11-01999]\] and algicidal \[[@B9-marinedrugs-11-01999]\] effects. In continuation of our search for new substances from marine invertebrates collected from the waters of Taiwan, the octocoral *Sinularia flexibilis* (Quoy and Gaimard, 1833) was studied ([Figure 1](#marinedrugs-11-01999-f001){ref-type="fig"}), as its organic extract was found to display meaningful signals in NMR studies. Three new cembrane-type diterpenoids, flexibilins A--C (**1**--**3**), and a known cembrane, (−)-sandensolide (**4**) \[[@B10-marinedrugs-11-01999],[@B22-marinedrugs-11-01999],[@B23-marinedrugs-11-01999]\], were isolated ([Figure 1](#marinedrugs-11-01999-f001){ref-type="fig"}). In this paper, we reported the isolation, structure determination and bioactivity of cembranes **1**--**4**.

![The soft coral, *Sinularia flexibilis*, and the structures of flexibilins A--C (**1**--**3**) and (−)-sandensolide (**4**).](marinedrugs-11-01999-g001){#marinedrugs-11-01999-f001}

2. Results and Discussion
=========================

Flexibilin A (**1**) was obtained as yellowish oil, and its molecular formula, C~20~H~32~O~5~, was determined according to a pseudomolecular ion \[M + Na\]^+^ at *m/z* 375.2144 (calcd. for C~20~H~32~O~5~Na, 375.2147) identified by HRESIMS, as well as ^13^C NMR coupled with DEPT spectra ([Table 1](#marinedrugs-11-01999-t001){ref-type="table"}), which indicated that the double bond equivalence (DBE) of **1** was five. The IR spectrum of **1** revealed the presence of carboxylic acid, hydroxy and ester functionalities from absorptions at 3750--2400, 3419 and 1711 cm^−1^, respectively. The ^13^C NMR data of **1** showed the presence of 20 carbon signals in total, which were assigned by the assistance of the DEPT spectrum to three methyls, seven sp^3^ methylenes, three sp^3^ methines, two sp^3^ quaternary carbons, an sp^2^ methylene, an sp^2^ methine and three sp^2^ quaternary carbons. ^13^C NMR signals appearing at *δ*~C~ 170.8 (C-16), 142.7 (C-15) and 126.5 (CH~2~-17) and proton NMR signals appearing at *δ*~H~ 6.40 (1H, s) and 5.68 (1H, s) suggested the presence of a α-exomethylene-carboxylic acid moiety. The main carbon skeleton of **1** was elucidated by ^1^H--^1^H COSY and HMBC experiments ([Table 1](#marinedrugs-11-01999-t001){ref-type="table"} and [Figure 2](#marinedrugs-11-01999-f002){ref-type="fig"}). From the ^1^H--^1^H COSY spectrum of **1**, it was possible to establish the separate spin systems of H-13/H~2~-14/H-1/H~2~-2/H~2~-3, H-5/H~2~-6/H~2~-7, H-9/H~2~-10/H~2~-11 and H-9/H~3~-19 (by allylic coupling). These data, together with the key HMBC correlations between protons and quaternary carbons, such as H~2~-2, H~2~-3, H~2~-6, H~3~-18/C-4; H~2~-6, H~2~-7, H~2~-10, H~3~-19/C-8; H~2~-10, H~2~-11, H-13, H~2~-14, H~3~-20/C-12; H~2~-2, H~2~-14, H~2~-17/C-15; and H~2~-17/C-16, permitted elucidation of the main carbon skeleton of **1**. The tertiary methyls at C-4, C-8 and C-12 were confirmed by HMBC correlations between H~3~-18/C-3, -4, -5; H~3~-19/C-7, -8, -9; and H~3~-20/C-11, -12, -13. Thus, from the reported data, the skeleton of **1** was identified as a cembrane-type diterpenoid with two rings.

marinedrugs-11-01999-t001_Table 1

###### 

^1^H (500 MHz, CDCl~3~) and ^13^C (125 MHz, CDCl~3~) NMR data and ^1^H--^1^H COSY and HMBC correlations for cembrane **1**.

  Position                     *δ*~H~ (*J* in Hz)                   *δ*~C~, Multiple   ^1^H--^1^H COSY    HMBC
  ---------------------------- ------------------------------------ ------------------ ------------------ ------------------------
  1                            2.70 br s                            38.1, CH           H~2~-2, H~2~-14    C-13
  2                            1.63 m; 1.52 m                       26.6, CH~2~        H-1, H~2~-3        C-1, -4, -14, -15
  3                            1.60 m; 1.53 m                       37.1, CH~2~        H~2~-2             C-2, -4, -5
  4                                                                 74.8, C                               
  5                            3.53 d (10.0)                        74.0, CH           H~2~-6             C-6, -7, -18
  6                            1.71 m; 1.59 m                       28.6, CH~2~        H-5, H~2~-7        C-4, -5, -7, -8
  7                            2.21 m; 2.14 m                       33.7, CH~2~        H~2~-6             C-5, -6, -8, -9, -19
  8                                                                 136.1, C                              
  9                            5.11 dd (6.5, 6.5)                   122.7, CH          H~2~-10, H~3~-19   C-7, -10, -11, -19
  10                           2.14 m                               23.1, CH~2~        H-9, H~2~-11       C-8, -9, -11, -12
  11                           2.01 ddd (14.0, 6.5, 3.0)            37.5, CH~2~        H~2~-10            C-9, -10, -12, -20
  1.42 ddd (14.0, 11.0, 3.0)                                                                              
  12                                                                60.3, C                               
  13                           2.87 dd (7.5, 5.5)                   61.2, CH           H~2~-14            C-11, -12, -14
  14                           1.85 ddd (14.0, 10.0, 5.5); 1.61 m   34.1, CH~2~        H-1, H-13          C-1, -2, -12, -13, -15
  15                                                                142.7, C                              
  16                                                                170.8, C                              
  17                           6.40 s; 5.68 s                       126.5, CH~2~                          C-1, -15, -16
  18                           1.26 s                               24.7, CH~3~                           C-3, -4, -5
  19                           1.67 s                               18.1, CH~3~        H-9                C-7, -8, -9
  20                           1.30 s                               17.1, CH~3~                           C-11, -12, -13

![^1^H--^1^H COSY and selected HMBC correlations (protons→quaternary carbons) for cembrane **1**.](marinedrugs-11-01999-g002){#marinedrugs-11-01999-f002}

The relative configuration of **1** was elucidated from the interactions observed in a NOESY experiment, as shown in [Figure 3](#marinedrugs-11-01999-f003){ref-type="fig"}. In the NOESY experiment of **1**, H-1 was found to be correlated with H~2~-14, but not with H-13; this, plus, the lack of correlation between H-13 and H~3~-20 demonstrated that H-1, H-13 and Me-20 were α-, β- and α-oriented, respectively. Additionally, correlations between H-9/H-5 and H-9/H-13, and the absence of correlation between H-9/H~3~-19, reflected the *E* geometry of the double bond at C-8/9. From modeling analysis, H-9 was found to be close to H-5 and H-13, when H-5 and H-13 were β-oriented. H~3~-18 was found to be correlated with H-5, but not with H-1, indicating that the 4-hydroxy group was α-oriented. Based on the above findings, the structure of **1** was elucidated, and the chiral carbons of **1** were assigned as 1*R*\*, 4*R*\*, 5*S*\*, 12*S*\* and 13*S*\*.

![Key NOESY correlations of **1**.](marinedrugs-11-01999-g003){#marinedrugs-11-01999-f003}

The new cembrane diterpene, flexibilin B (**2**), had the molecular formula, C~20~H~30~O~5~, as deduced by HRESIMS (*m/z* calcd.: 373.1991; found 373.1989 \[M + Na\]^+^) (6° of unsaturation). The IR spectrum of **2** revealed the presence of carboxylic acid (ν~max~ 3700--2400 cm^−1^), hydroxy (ν~max~ 3447 cm^−1^) and carbonyl (ν~max~ 1713 cm^−1^) moieties. From the ^13^C NMR and DEPT spectra of **2** ([Table 2](#marinedrugs-11-01999-t002){ref-type="table"}), a trisubstituted olefin (*δ*~C~ 134.5, C-8; 126.5, CH-9), a α-exomethylene-carboxylic acid (*δ*~C~ 171.3, C-16; 141.9, C-15; 126.2, CH~2~-17), a keto carbonyl (*δ*~C~ 213.6, C-5) and a trisubstituted epoxide (*δ*~C~ 60.8, C-12; 59.4, CH-13) were observed. The coupling information in the ^1^H--^1^H COSY spectrum of **2** enabled identification of the H-13/H~2~-14/H-1/H~2~-2/H~2~-3, H~2~-6/H~2~-7, H-9/H~2~-10/H~2~-11 and H-9/H~3~-19 (by allylic coupling) units. From these data, together with the results of an HMBC experiment for **2**([Table 2](#marinedrugs-11-01999-t002){ref-type="table"} and [Figure 4](#marinedrugs-11-01999-f004){ref-type="fig"}), the molecular framework of **2** could be established.
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###### 

^1^H (500 MHz, CDCl~3~) and ^13^C (125 MHz, CDCl~3~) NMR data and ^1^H--^1^H COSY and HMBC correlations for cembrane **2**.

  Position   *δ*~H~ (*J* in Hz)   *δ*~C~, Multiple   ^1^H--^1^H COSY    HMBC
  ---------- -------------------- ------------------ ------------------ ----------------------
  1          2.75 m               35.9, CH           H~2~-2, H~2~-14    C-14
  2          1.59 m; 1.41 m       25.1, CH~2~        H-1, H~2~-3        C-4, -15
  3          1.78 m; 1.52 m       35.8, CH~2~        H~2~-2             C-4, -5, -18
  4                               78.9, C                               
  5                               213.6, C                              
  6          2.70 m               34.2, CH~2~        H~2~-7             C-5, -7, -8
  7          2.55 m; 2.21 m       31.5, CH~2~        H~2~-6             C-5, -6, -8, -9, -19
  8                               134.5, C                              
  9          5.13 dd (6.0, 6.0)   126.5, CH          H~2~-10, H~3~-19   C-7, -10, -11, -19
  10         2.10 m; 2.01 m       22.8, CH~2~        H-9, H~2~-11       C-8, -9, -11, -12
  11         1.96 m; 1.56 m       36.7, CH~2~        H~2~-10            C-9, -10, -12, -13
  12                              60.8, C                               
  13         2.79 dd (9.5, 4.0)   59.4, CH           H~2~-14            C-14
  14         1.99 m; 1.42 m       32.4, CH~2~        H-1, H-13          C-1, -12, -13, -15
  15                              141.9, C                              
  16                              171.3, C                              
  17         6.42, s; 5.57 s      126.2, CH~2~                          C-1, -15, -16
  18         1.35 s               25.7, CH~3~                           C-3, -4, -5
  19         1.66 s               17.0, CH~3~        H-9                C-7, -8, -9
  20         1.27 s               18.2, CH~3~                           C-11, -12, -13

![^1^H--^1^H COSY and selected HMBC correlations (protons→quaternary carbons) for cembrane **2**.](marinedrugs-11-01999-g004){#marinedrugs-11-01999-f004}

The relative stereochemistry of **2** was elucidated from the interactions observed in a NOESY experiment ([Figure 5](#marinedrugs-11-01999-f005){ref-type="fig"}). Due to the α-orientation of H-1, the epoxy proton, H-13, was identified as being β-oriented, as no correlation was observed between H-1 and H-13. H-9 displayed correlations with H-13 and one of the C-7 methylene protons (*δ*~H~ 2.55), and there was a lack of correlation between H-9 and H~3~-19, which reflects the *E* geometry of the double bond between C-8/9. H~3~-20 showed correlations with H-9 and H-13, indicating that Me-20 is of a β-orientation at C-12. Furthermore, H-1 was found to be correlated with H~2~-3, and H~3~-18 exhibited a correlation with one of the C-3 methylene protons (*δ*~H~ 1.78), which indicated the β-orientation of Me-18 at C-4 by molecular modeling analysis. Based on the above information, the chiral carbons of cembrane **2** were assigned as 1*R*\*, 4*R*\*, 12*R*\* and 13*S*\*.

![Key NOESY correlations of **2**.](marinedrugs-11-01999-g005){#marinedrugs-11-01999-f005}

Flexibilin C (**3**) was obtained as a white powder. The molecular formula of **3**was established as C~20~H~30~O~5~ (6° of unsaturation) from a sodiated molecule at *m/z* 373 in the ESIMS spectrum and further supported by HRESIMS (*m/z* 373.1989, calcd. for C~20~H~30~O~5~Na, 373.1991). The IR spectrum of **3** exhibited the presence of hydroxy (ν~max~ 3431 cm^−1^) and carbonyl (ν~max~ 1711 cm^−1^) groups. From the ^13^C NMR data of **3** ([Table 3](#marinedrugs-11-01999-t003){ref-type="table"}), a suite of resonances at *δ*~C~ 168.0 (C-16), 143.3 (C-15), 126.0 (CH~2~-17), 90.0 (C-4), 37.4 (CH-1), 33.7 (CH~2~-3) and 29.7 (CH~2~-2) could be assigned to the α-exomethylene-ε-lactone moiety. Two additional unsaturated functionalities were indicated by ^13^C resonances at *δ*~C~ 209.3 (C-5), 134.7 (C-8) and 124.9 (CH-9), suggesting the presence of a keto carbonyl and a trisubstituted olefin. On the basis of the overall unsaturation data, **3** was concluded to be a diterpenoid molecule possessing two rings. The ^1^H NMR spectrum of **3** showed the presence of three methyl groups: two singlets at *δ*~H~ 1.27 and 1.49, representing the methyl groups on oxygenated quaternary carbons, respectively, and a vinyl methyl at *δ*~H~ 1.69. The ^1^H NMR coupling information in the ^1^H--^1^H COSY spectrum of **3** enabled identification of the H-13/H~2~-14/H-1/H~2~-2/H~2~-3, H~2~-6/H~2~-7, H-9/H~2~-10/H~2~-11 and H-9/H~3~-19 (by allylic coupling) units, which were assembled with the assistance of an HMBC experiment ([Table 3](#marinedrugs-11-01999-t003){ref-type="table"} and [Figure 6](#marinedrugs-11-01999-f006){ref-type="fig"}). The key HMBC correlations between protons and quaternary carbons of **3**, such as H~2~-2, H~2~-3, H~3~-18/C-4; H~2~-3, H~2~-6, H~2~-7, H~3~-18/C-5; H~2~-6, H~2~-7, H~2~-10, H~3~-19/C-8; H~2~-10, H~2~-11, H~2~-14, H~3~-20/C-12; H-1, H~2~-2, H~2~-14, H~2~-17/C-15; and H-1, H~2~-17, H~3~-18/C-16, enabled establishment of the main carbon skeleton of **3**. A vinyl methyl at C-8 was confirmed by the allylic coupling between H-9/H~3~-19 in the ^1^H--^1^H COSY spectrum and by the HMBC correlations between H~3~-19/C-7, -8, -9. The tertiary methyls at C-4 and C-12 were confirmed by the HMBC correlations between H~3~-18/C-3, -4, -5, and H~3~-20/C-11, -12, -13. H~3~-18 showed a long-range ^4^*J*-correlation with the ester carbonyl (*δ*~C~ 168.0, C-16) in the HMBC spectrum, which further supported the existence of the ε-lactone moiety in **3**.

marinedrugs-11-01999-t003_Table 3

###### 

^1^H (500 MHz, CDCl~3~) and ^13^C (125 MHz, CDCl~3~) NMR data and ^1^H--^1^H COSY and HMBC correlations for cembrane **3**.

  Position                     *δ*~H~ (*J* in Hz)                      *δ*~C~, Multiple   ^1^H--^1^H COSY    HMBC
  ---------------------------- --------------------------------------- ------------------ ------------------ ---------------------------
  1                            1.90 m                                  37.4, CH           H~2~-2, H~2~-14    C-2, -14, -15, -16, -17
  2                            2.19 m; 1.20 ddd (12.5, 12.5, 7.0)      29.7, CH~2~        H-1, H~2~-3        C-1, -2, -3, -4, -14, -15
  3                            2.45 dd (15.5, 7.0); 1.91 m             33.7, CH~2~        H~2~-2             C-1, -2, -4, -5, -18
  4                                                                    90.0, C                               
  5                                                                    209.3, C                              
  6                            3.36 dd (17.0, 9.5); 2.56 br d (17.0)   33.6, CH~2~        H~2~-7             C-5, -7, -8
  7                            2.57 br d (16.0); 2.15 m                31.0, CH~2~        H~2~-6             C-5, -6, -8, -9, -19
  8                                                                    134.7, C                              
  9                            4.99 dd (6.5, 6.5)                      124.9, CH          H~2~-10, H~3~-19   C-7, -9, -10, -19
  10                           2.14 m                                  23.5, CH~2~        H-9, H~2~-11       C-8, -9, -11, -12
  11                           1.66 m                                  38.2, CH~2~        H~2~-10            C-9, -10, -12, -13, -20
  12                                                                   76.2, C                               
  13                           3.26 dd (6.0, 1.5)                      75.5, CH           H~2~-14            C-1, -11, -14, -20
  14                           2.03 dd (14.5, 1.5)                     35.3, CH~2~        H-1, H-13          C-1, -2, -12, -13, -15
  1.40 ddd (14.5, 11.0, 6.0)                                                                                 
  15                                                                   143.3, C                              
  16                                                                   168.0, C                              
  17                           6.35 s; 5.58 s                          126.0, CH~2~                          C-1, -15, -16
  18                           1.49 s                                  29.6, CH~3~                           C-3, -4, -5, -16
  19                           1.69 s                                  17.4, CH~3~        H-9                C-7, -8, -9
  20                           1.27 s                                  24.6, CH~3~                           C-11, -12, -13

![^1^H--^1^H COSY and selected HMBC correlations (protons→quaternary carbons) for cembrane **3**.](marinedrugs-11-01999-g006){#marinedrugs-11-01999-f006}

The relative stereochemistry of **3** was elucidated by the analysis of NOE correlations, as shown in [Figure 7](#marinedrugs-11-01999-f007){ref-type="fig"}. H-9 exhibited a correlation with one of the C-6 methylene protons (*δ*~H~ 3.36), but not with H~3~-19, which revealed the *E* geometry of the C-8/9 double bond. It was found that H-13 showed correlations with H-1 and H-9. From molecular modeling analysis, H-13 was found to be close to H-1 and H-9, when H-1 and H-13 were α-oriented. Correlations observed between H~3~-20/H-13 and H~3~-20/H~2~-10 reflected the β-orientation of Me-20. Furthermore, H~3~-18 exhibited correlations with C-3 methylene protons and the lack of correlation between H~3~-18 and H-1, indicating that Me-18 was positioned on the β-face in **3**. Thus, the structure of **3** was established, and the chiral carbons of **3** were assigned as 1*R*\*, 4*R*\*, 12*R*\* and 13*S*\*.

![Key NOESY correlations of **3**.](marinedrugs-11-01999-g007){#marinedrugs-11-01999-f007}

The known cembrane, (−)-sandensolide (**4**), was first isolated from a Chinese soft coral, *Dendronephthya* sp. \[[@B23-marinedrugs-11-01999]\], and its structure was elucidated by spectroscopic methods and by comparison of spectral (1D and 2D NMR) and physical (rotation value) data with those of its enantiomer, sandensolide \[[@B10-marinedrugs-11-01999],[@B22-marinedrugs-11-01999]\]. In this study, the structure of **4**, including its absolute stereochemistry, was further established by single-crystal X-ray diffraction analysis for the first time. The X-ray structure of **4** ([Figure 8](#marinedrugs-11-01999-f008){ref-type="fig"}) demonstrates the *E* geometry of the C-8/9 and C-11/12 double bonds, and the absolute configurations for all chiral carbons were assigned as 1*R*, 4*R*, 5*S* and 13*S*. As flexibilins A--C (**1**--**3**) were isolated, along with (−)-sandensolide (**4**), from the same organism, it is reasonable on biogenetic grounds to assume that cembranes **1**--**3** have the same absolute configurations as **4**.

![Molecular plot of **4** with confirmed absolute configuration.](marinedrugs-11-01999-g008){#marinedrugs-11-01999-f008}

The *in vitro* anti-inflammatory effects of cembranes **1**--**4** were examined, and cembrane **2** displayed a moderate inhibitory effect on the release of elastase by human neutrophils ([Table 4](#marinedrugs-11-01999-t004){ref-type="table"}) \[[@B24-marinedrugs-11-01999]\].
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###### 

Inhibitory effects of cembranes **1**--**4** on the generation of superoxide anions and the release of elastase by human neutrophils in response to fMLP/CB.

  Compound           Superoxide anions   Elastase release                  
  ------------------ ------------------- ------------------- ------------- ---------------------
  **1**              \>10                12.31 ± 3.04 \*     \>10          22.67 ± 5.32 \*
  **2**              \>10                22.03 ± 3.88 \*\*   \>10          45.76 ± 2.92 \*\*\*
  **3**              \>10                18.80 ± 3.81 \*\*   \>10          10.56 ± 2.75 \*
  **4**              \>10                −2.08 ± 1.01        \>10          8.14 ± 4.03
  **LY294002 ^b^**   0.41 ± 0.27                             0.79 ± 0.18   

^a^Percentage of inhibition (Inh%) at a concentration of 10 μg/mL. ^b^ LY294002, a phosphatidylinositol-3-kinase inhibitor, was used as a positive control for inhibition of superoxide anion generation and elastase release. The results are presented as the mean ± S.E.M. (*n* = 3 or 4). \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001, compared with the control value.

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotations were measured on a Jasco P-1010 digital polarimeter. Infrared spectra were recorded on a Varian Diglab FTS 1000 FT-IR spectrometer; peaks are reported in cm^−1^. The NMR spectra were recorded on a Varian Inova 500 or on a Varian Mercury Plus 400 NMR spectrometer using the residual CHCl~3~ signal (*δ*~H~ 7.26 ppm) as the internal standard for ^1^H NMR and CDCl~3~ (*δ*~C~ 77.1 ppm) for ^13^C NMR. Coupling constants (*J*) are given in Hz. ESIMS and HRESIMS were recorded on a Bruker APEX II mass spectrometer. Column chromatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F~254~ (0.25 mm, Merck); spots were visualized by spraying with 10% H~2~SO~4~ solution, followed by heating. HPLC was performed using a system comprised of a Hitachi L-7110 pump and a Rheodyne injection port. A normal phase semi-preparative column (Supelco Ascentis^®^ Si cat\#:581515-U, 250 × 21.2 mm, 5 μm) was used for HPLC.

3.2. Animal Material
--------------------

Specimens of the octocoral *S. flexibilis* were collected by hand using scuba equipment off the coast of southern Taiwan in July, 2011, and stored in a freezer until extraction. A voucher specimen (NMMBA-TWSC-11005) was deposited in the National Museum of Marine Biology and Aquarium, Taiwan.

3.3. Extraction and Isolation
-----------------------------

Sliced bodies of the soft coral *S. flexibilis* (wet weight 3.0 kg, dry weight 950 g) were extracted with ethyl acetate (EtOAc). The EtOAc layer was separated by silica gel and eluted using *n*-hexane/EtOAc in a stepwise fashion from pure *n*-hexane--100:1--pure EtOAc to yield 11 fractions, A--K. Fraction J was chromatographed on silica gel and eluted using *n*-hexane/EtOAc (stepwise, 2:1--1:1) to afford subfractions 1--10. Fractions J3, J5 and J9 were separated by normal-phase HPLC (NP-HPLC) using a mixture of *n*-hexane and acetone as the mobile phase to afford **4** (3:1, 74.3 mg), **3** (2:1, 5.6 mg) and **2** (3:1, 16.6 mg), respectively. Fraction K was further purified by NP-HPLC using a mixture of *n*-hexane and acetone as the mobile phase to afford **1** (2:1, 22.4 mg).

Flexibilin A (**1**): yellowish oil; ![](marinedrugs-11-01999-i001.jpg) −9 (*c* 0.47, CHCl~3~); IR (neat) ν~max~ 3750--2400 (br.), 3419, 1711 cm^−1^; ^1^H (CDCl~3~, 500 MHz) and ^13^C (CDCl~3~, 125 MHz) NMR data---see [Table 1](#marinedrugs-11-01999-t001){ref-type="table"}; ESIMS: *m/z* 375 (M + Na)^+^; HRESIMS: *m/z* 375.2144 (calcd. for C~20~H~32~O~5~Na, 375.2147).

Flexibilin B (**2**): colorless oil; ![](marinedrugs-11-01999-i001.jpg) +29 (*c* 0.83, CHCl~3~); IR (neat) ν~max~ 3700--2400 (br.), 3447, 1713 cm^−1^; ^1^H (CDCl~3~, 500 MHz) and ^13^C (CDCl~3~, 125 MHz) NMR data---see [Table 2](#marinedrugs-11-01999-t002){ref-type="table"}; ESIMS: *m/z* 373 (M + Na)^+^; HRESIMS: *m/z* 373.1989 (calcd. for C~20~H~30~O~5~Na, 373.1991).

Flexibilin C (**3**): white powder; mp 95--97 °C; ![](marinedrugs-11-01999-i001.jpg) +4 (*c* 0.28, CHCl~3~); IR (neat) ν~max~ 3431, 1711 cm^−1^; ^1^H (CDCl~3~, 500 MHz) and ^13^C (CDCl~3~, 125 MHz) NMR data---see [Table 3](#marinedrugs-11-01999-t003){ref-type="table"}; ESIMS: *m/z* 373 (M + Na)^+^; HRESIMS: *m/z* 373.1989 (calcd. for C~20~H~30~O~5~Na, 373.1991).

(−)-Sandensolide (**4**): white powder; mp 178--180 °C; ![](marinedrugs-11-01999-i001.jpg) −43 (*c* 0.67, CHCl~3~) (reference \[[@B23-marinedrugs-11-01999]\], ![](marinedrugs-11-01999-i002.jpg) −45.0 (*c* 0.5, CHCl~3~)); IR (neat) ν~max~ 3431, 1691 cm^−1^; ^1^H NMR (CDCl~3~, 400 MHz) *δ*~H~ 6.24 (1H, s, H-17), 5.49 (1H, s, H-17′), 5.39 (1H, m, H-11), 5.36 (1H, m, H-9), 4.18 (1H, dd, *J* = 11.2, 4.4 Hz, H-13), 3.77 (1H, d, *J* = 10.4 Hz, H-5), 3.13 (1H, ddd, *J* = 13.2, 11.6, 10.4 Hz, H-10), 2.40 (1H, m, H-10′), 2.21 (1H, m, H-7), 2.13 (1H, m, H-3), 2.05 (1H, m, H-7′), 2.04 (1H, m, H-2), 2.01 (1H, m, H-1), 1.99 (1H, m, H-6), 1.80 (1H, m, H-14), 1.72 (1H, m, H-14′), 1.70 (1H, m, H-3′), 1.62 (3H, s, H~3~-18), 1.52 (3H, s, H~3~-19), 1.35 (1H, dddd, *J* = 14.0, 10.4, 3.6, 3.6 Hz, H-6′), 1.26 (3H, s, H~3~-20), 1.14 (1H, m, H-2′); ^13^C NMR (CDCl~3~, 100 MHz) *δ*~C~ 169.6 (C-16), 144.6 (C-15), 134.2 (C-8), 132.7 (C-12), 127.9 (CH-11), 124.7 (CH-9), 124.4 (CH~2~-17), 86.6 (C-4), 76.6 (CH-13), 67.4 (CH-5), 38.0 (CH~2~-14), 34.8 (CH~2~-7), 33.7 (CH-1), 32.0 (CH~2~-3), 29.2 (CH~2~-2), 26.8 (CH~2~-10), 26.6 (CH~2~-6), 22.8 (CH~3~-18), 14.9 (CH~3~-19), 9.3 (CH~3~-20); ESIMS: *m/z* 357 (M + Na)^+^; HRESIMS: *m/z* 357.2040 (calcd. for C~20~H~30~O~4~Na, 357.2042).

3.4. Single-Crystal X-ray Crystallography of *(−)*-Sandensolide *(**4**) \[[@B25-marinedrugs-11-01999]\]*
---------------------------------------------------------------------------------------------------------

Suitable colorless prisms of **4** were obtained from a solution of ethyl acetate. Crystal data and experimental details: C~20~H~30~O~4~, *M~r~* = 334.44, crystal size 0.25 × 0.20 × 0.20 mm, crystal system monoclinic, space group *P*2~1~ (\#4), with *a* = 9.0281(3) Å, *b* = 22.2200(8) Å, *c* = 9.3289(3) Å, β = 100.547(1)°, *V* = 1839.80(11) Å,^3^, *Z* = 4, *D*~calcd~ = 1.207 g/cm^3^ and λ (Cu, kα) = 1.54178 Å. Intensity data were measured on a Bruker APEX-II CCD diffractometer equipped with a micro-focus Cu radiation source and Montel mirror up to *θ*~max~ of 26° at 100 K. All 5454 reflections were collected. The structure was solved by direct methods and refined by a full-matrix least-squares procedure. The refined structural model converged to a final *R*1 = 0.0294, *wR*2 = 0.0759 for 5398 observed reflection \[*I* \> 2σ(*I*)\] and 455 variable parameters. The absolute configuration was determined by Flack's method, with the Flack's parameter determined as 0.06(10) \[[@B26-marinedrugs-11-01999]\].

3.5. Generation of Superoxide Anions and Release of Elastase by Human Neutrophils
---------------------------------------------------------------------------------

Human neutrophils were obtained by means of dextran sedimentation and Ficoll centrifugation. Measurements of superoxide anion generation and elastase release were carried out according to previously described procedures \[[@B27-marinedrugs-11-01999],[@B28-marinedrugs-11-01999],[@B29-marinedrugs-11-01999],[@B30-marinedrugs-11-01999],[@B31-marinedrugs-11-01999],[@B32-marinedrugs-11-01999],[@B33-marinedrugs-11-01999]\]. Briefly, superoxide anion production was assayed by monitoring the superoxide dismutase-inhibitable reduction of ferricytochrome *c*. Elastase release experiments were performed using MeO-Suc-Ala-Ala-Pro-Valp-nitroanilide as the elastase substrate.

4. Conclusions
==============

Cembrane-type diterpenoids are the major component of the organic extract of the soft coral, *Sinularia flexibilis*, collected from the waters of Taiwan, and compounds of this type have been shown to have the potential for use in medical applications. Our studies of *S. flexibilis* have led to the isolation of three new cembranes, flexibilins A--C (**1**--**3**), along with a known metabolite, (−)-sandensolide (**4**), and flexibilin B (**2**) displayed a moderate inhibitory effect on the release of elastase by human neutrophils. In addition to marine organisms, cembrane-type diterpenoids are also found in higher plants and bryophytes \[[@B34-marinedrugs-11-01999],[@B35-marinedrugs-11-01999],[@B36-marinedrugs-11-01999],[@B37-marinedrugs-11-01999],[@B38-marinedrugs-11-01999],[@B39-marinedrugs-11-01999],[@B40-marinedrugs-11-01999],[@B41-marinedrugs-11-01999],[@B42-marinedrugs-11-01999],[@B43-marinedrugs-11-01999]\]. However, the carboxylic acid moieties exhibited in cembranes **1** and **2** are rarely found \[[@B35-marinedrugs-11-01999],[@B44-marinedrugs-11-01999]\]. The soft coral, *S. flexibilis*, has begun to be transplanted to culturing tanks with a flow-through seawater system located in the National Museum of Marine Biology and Aquarium, Taiwan, for exhibition and the extraction of additional natural products in order to establish a stable supply of bioactive material.
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